BC
XLRN

Brookfield Corp’s Acceleron Pharma XLRN Stock Holding History

Brookfield Corp’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,500
Closed -$1.64M – 773
2021
Q3 		$1.64M Buy
+9,500
New +$1.24M 0.01% 375

Brookfield Corp's XLRN Position: Q4 2021 in Review

Brookfield Corp sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 9,500 shares — an estimated $1.64M sold.

Brookfield Corp first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $1.64M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Brookfield Corp reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Brookfield Corp sold 9,500 Acceleron Pharma shares in Q4 2021, an estimated $1.64M.
  • Brookfield Corp first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Brookfield Corp's Acceleron Pharma position peaked at $1.64M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Brookfield Corp's 13F filing for Q4 2021, filed 14 Feb 2022.